Chemours (CC) FY2025 results: revenue $5.8 billion, up 0.4% on the year
Chemours Co. (CC) reported revenue of $5.8 billion for fiscal 2025, the year ended 31 December 2025, up 0.4% on the year before. Net income was -$386 million, and diluted earnings per share $-2.57. The figures are the company's own, from the 10-K it filed with the SEC on 24 February 2026.
Revenue
$5.8 billion
+0.4% on the year
FY2018FY2025
Operating margin
-1.1%
5.7% a year earlier
FY2018FY2025
Net income
-$386 million
FY2018FY2025
Diluted EPS
-$2.57
FY2018FY2025
this yearthe year beforeHover a bar for its figure.
The year in brief
What management said about the year
Guidance figures: 18 new.
Net loss widened on charges: Net loss attributable to Chemours was $47 million, or $0.31 per diluted share, against a $0.08 loss a year earlier, with lower cost absorption as a main driver.
Adjusted EBITDA down 24%: Adjusted EBITDA fell to $128 million from $168 million, and adjusted diluted EPS was $0.05 against $0.09 a year earlier.
TSS record quarter, Opteon up 37%: TSS reported a record fourth quarter, with Opteon Refrigerants sales up 37% year over year.
TT sales and EBITDA fell sharply: TT net sales fell 11% to $561 million, with price down 6% and volume down 6%; Adjusted EBITDA fell 67%, to a 4% margin.
APM earnings cut by inventory charge: APM Adjusted EBITDA fell 74% to a 4% margin, after a non-cash inventory charge and a less favorable product mix.
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2025
FY2024
FY2023
On the year
Last 8 years
Operating cash flow
264
-633
556
Capital expenditure
213
360
370
-40.8%
Free cash flow
51.0
-993
186
Free cash flow margin
0.9%
-17.2%
3.1%
Cash from investing
-206
-353
-229
Cash from financing
-126
-36.0
172
Depreciation and amortisation
340
292
309
+16.4%
Share-based compensation
21.0
15.0
18.0
+40.0%
Buybacks
n/a
n/a
69.0
Dividends paid
78.0
148
149
-47.3%
Dividend per share
$0.51
$1.00
$1.00
-48.8%
Diluted shares, weighted
150m
150m
149m
+0.0%
Shares outstanding at period end
150m
149m
149m
+0.3%
Balance sheet
$ million
FY2025
FY2024
FY2023
On the year
Last 8 years
Shareholders' equity
250
571
721
-56.2%
Non-controlling interest
1.0
1.0
2.0
0.0%
Debt
4,141
4,113
4,038
+0.7%
Operating lease liabilities
191
198
208
-3.5%
Finance lease liabilities
28.0
38.0
46.0
-26.3%
Other liabilities
2,771
2,594
3,236
+6.8%
Total liabilities and equity
7,382
7,515
8,251
-1.8%
Fixed assets
3,078
3,183
3,207
-3.3%
Goodwill
46.0
46.0
102
0.0%
Intangible assets
2.0
3.0
3.0
-33.3%
Cash and equivalents
670
713
1,203
-6.0%
Receivables
562
619
509
-9.2%
Inventory
1,569
1,463
1,349
+7.2%
Other assets
1,455
1,488
1,878
-2.2%
Total assets
7,382
7,515
8,251
-1.8%
10-K for the year ended 31 December 2025, filed 24 February 2026: the filing.